By Nigam Arora & Dr. Natasha Arora
A fortune is to be made by buying stocks in companies that get bought out. To date 167 of Arora Portfolio companies have been bought out producing a fortune for long time subscribers.
Momentive (MNTV) is the maker of popular survey software Surveymonkey. There is speculation that the company is looking to sell itself.
The buyout can happen in the zone of $28 – $32. However, the probability is better than 60% that the stock will pull back first. For this reason, most investors may consider following the Best Way. To learn about the Best Way, please see your Getting A Running Start Guide.
For those following the Best Way, the Buy Zone is $18.56 – $20.78.
For those following the Good Way and are super aggressive, the Buy Now rating is ‘YES’ but only to start a small scale in.
The recommended position size is 30% of full core position size. To learn about position size, please see Trade Management Guidelines.
The stop zone is $17.11 – $17.23.
MNTV is trading at $23.15 as of this writing.
To take a free 30-day trial to paid services to gain access to more opportunities, please click here.
This post was just published on ZYX Buy Change Alert.
Markets can generate substantial wealth for knowledgeable investors. NOW YOU TOO CAN ALSO SPECTACULARLY SUCCEED AT MEETING YOUR GOALS WITH THE HELP OF THE ARORA REPORT. You are receiving less than 2% of the content from our paid services. …TO RECEIVE REMAINING 98% INCLUDING MANY ATTRACTIVE INVESTMENT OPPORTUNITIES,
TAKE A FREE TRIAL TO PAID SERVICES.
Please click here to take advantage of a FREE 30 day trial.
Nigam Arora
Nigam Arora is known for his accurate stock market calls. Nigam is a distinguished master of the macro. He is a popular columnist with over 100 million page views, an engineer, and nuclear physicist by background. Nigam has founded two Inc. 500 fastest growing companies and has been involved in over 50 entrepreneurial ventures. He is the developer of Theory ZYX of Successful Change Management and is the author of the book on Theory ZYX, as well as the developer of the ZYX Change Method for Investing.
Dr. Natasha Arora
Dr. Natasha Arora has significant expertise in investment analysis especially biotech, healthcare, and technology. Natasha is a graduate of Harvard Medical School followed by a postdoc at MIT. She has published several peer reviewed research papers in top science journals.
